Verdict91/ 100
Grade A− · #2Eden
A polished, high-disclosure compounded program with strong nationwide coverage.
Visit EdenHead-to-head verdict
Eden vs ShedRx
Two GLP-1 providers, ruled side by side on The Verdict Score — our published six-factor rubric. Same yardstick, and no score is adjusted for payment.
vs
Verdict87/ 100
Grade B+ · #4ShedRx
Four routes to the same molecule — injection, drops, lozenges and an oral pill — plus real brand Zepbound, with health coaching bundled in.
Visit ShedRxThe verdict
Winner: Eden
Eden takes it with a higher Verdict Score — 91/100 to 87/100 (grade A− vs B+). People who prioritize a vetted, high-transparency provider over the lowest sticker price. ShedRx still earns its place — people who want options rather than one route: a needle-free form, a brand pathway, or coaching included instead of sold separately.
Neither of these is our overall #1. That title goes to CoreAge Rx (94/100) — the most honest middle of the market: nationwide access, both molecules at one flat, no-surprise price.
Factor by factor
Both scored on the same six factors — see the methodology. The brass bar marks the stronger side on each.
90Real-world results86
90
Real-world results86
89Price honesty86
89
Price honesty86
95Prescriber access83
95
Prescriber access83
86Formulary choice90
86
Formulary choice90
90Cancellation fairness88
90
Cancellation fairness88
92Member support88
92
Member support88
Price, coverage & features
| Metric | Eden | ShedRx |
|---|---|---|
| Verdict Score | 91/100 | 87/100 |
| Grade | A− | B+ |
| Semaglutide | $239/mo | $199/mo |
| Tirzepatide | $349/mo | $299/mo |
| Coverage | All 50 states | All 50 states |
| Brand-name access | Compounded only | Yes |
| Oral / sublingual | No | Yes |
Eden
What we like
- High verification confidence — clear supply-chain and clinician disclosure
- Nationwide availability
- Both molecules offered
The caveats
- Premium pricing vs the cheapest tiers
- Compounded only — no brand-name access
- FDA issued a warning letter to Eden Health International Inc. dba Eden in June 2026; it is public in FDA's warning-letter database
ShedRx
What we like
- Four routes to a GLP-1 — injection, liquid drops, lozenges and an oral daily pill — plus brand Zepbound and Wegovy
- Tirzepatide $299/mo month-to-month falling to $239 on a twelve-month plan; semaglutide $199 falling to $159
- Health coaching included with membership rather than upsold
- Publishes a 120-day weight-loss guarantee, which almost nothing else here offers
The caveats
- The advertised "as low as $239" tirzepatide rate requires committing to twelve months — month-to-month is $299
- Compounded medication is not FDA-approved the way brand Ozempic, Wegovy, or Zepbound are
- The dispensing compounding pharmacy is not publicly named
Our pick — visit
People who prioritize a vetted, high-transparency provider over the lowest sticker price.
Visit Eden Read the full Eden review →Also worth a look
People who want options rather than one route: a needle-free form, a brand pathway, or coaching included instead of sold separately.
Visit ShedRx Read the full ShedRx review →Keep comparing
Neither of these has to be the answer: the rivals we rank against Eden cover the 7 programs closest to it, and the same shortlist for ShedRx does the reverse.
Or browse the full comparison hub and the complete rankings.
Pricing, states and verification reflect each provider's public disclosures at last review; the Verdict Score is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.